Christopher German's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 5,614 Common Stock done at an average price of $89.6 . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 89.56 per share. | 04 Mar 2026 | 5,614 | 160 (0%) | 0% | 89.6 | 502,790 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 1,500 | 3,731 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.97 per share. | 04 Mar 2026 | 1,500 | 5,753 (0%) | 0% | 18.0 | 26,955 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 1,162 | 4,595 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 1,162 | 1,162 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.94 per share. | 01 Mar 2026 | 342 | 4,253 (0%) | 0% | 94.9 | 32,469 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 5,215 | 5,215 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 3,613 | 4,571 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 1,807 | 5,418 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 1,806 | 3,612 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.99 per share. | 01 Feb 2026 | 1,138 | 3,433 (0%) | 0% | 109.0 | 124,031 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 12 Aug 2025 | 1,500 | 922 (0%) | 0% | 95 | 142,500 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 1,000 | 5,231 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.97 per share. | 12 Aug 2025 | 1,000 | 1,922 (0%) | 0% | 18.0 | 17,970 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 500 | 4,050 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.23 per share. | 12 Aug 2025 | 500 | 1,422 (0%) | 0% | 49.2 | 24,615 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 2,000 | 6,231 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.97 per share. | 09 Jul 2025 | 2,000 | 3,889 (0%) | 0% | 18.0 | 35,940 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 76.75 per share. | 09 Jul 2025 | 1,967 | 2,772 (0%) | 0% | 76.7 | 150,967 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 09 Jul 2025 | 1,850 | 922 (0%) | 0% | 85 | 157,250 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 850 | 4,550 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.23 per share. | 09 Jul 2025 | 850 | 4,739 (0%) | 0% | 49.2 | 41,846 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 67.19 per share. | 10 Jun 2025 | 2,069 | 1,889 (0%) | 0% | 67.2 | 139,016 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 1,069 | 8,231 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.97 per share. | 10 Jun 2025 | 1,069 | 3,958 (0%) | 0% | 18.0 | 19,210 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2025 | 1,163 | 3,233 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2025 | 1,163 | 2,324 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 54.23 per share. | 20 Mar 2025 | 344 | 2,889 (0%) | 0% | 54.2 | 18,655 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 7,225 | 7,225 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 5,400 | 5,400 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 1,807 | 2,705 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 1,807 | 5,418 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 57.22 per share. | 14 Feb 2025 | 635 | 2,070 (0%) | 0% | 57.2 | 36,335 | Common Stock |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 1,163 | 1,163 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 1,163 | 3,487 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 41.76 per share. | 20 Mar 2024 | 368 | 795 (0%) | 0% | 41.8 | 15,368 | Common Stock |
| Rhythm Pharma Inc | German Christopher | Corporate Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 7,225 | 7,225 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Christopher German | Corporate Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 5,400 | 5,400 | - | - | Stock Option (Right to Buy) |